Cargando…

Role of biomarkers in evaluation, treatment and clinical studies of pulmonary arterial hypertension

Pulmonary arterial hypertension is a complex disease resulting from the interplay of myriad biological and environmental processes that lead to remodeling of the pulmonary vasculature with consequent pulmonary hypertension. Despite currently available therapies, there remains significant morbidity a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hemnes, Anna, Rothman, Alexander M.K., Swift, Andrew J., Zisman, Lawrence S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682212/ https://www.ncbi.nlm.nih.gov/pubmed/33282185 http://dx.doi.org/10.1177/2045894020957234

Ejemplares similares

Identifying “super responders” in pulmonary arterial hypertension
por: Halliday, Stephen J., et al.
Publicado: (2017)

Evolution and optimization of clinical trial endpoints and design in pulmonary arterial hypertension
por: Caccamo, Marco, et al.
Publicado: (2023)

Pulmonary Artery Denervation Reduces Pulmonary Artery Pressure and Induces Histological Changes in an Acute Porcine Model of Pulmonary Hypertension
por: Rothman, Alexander M.K., et al.
Publicado: (2015)

TORREY, a Phase 2 study to evaluate the efficacy and safety of inhaled seralutinib for the treatment of pulmonary arterial hypertension
por: Frantz, Robert P., et al.
Publicado: (2021)

Pathobiology of pulmonary arterial hypertension: understanding the roads less travelled
por: Hemnes, Anna R., et al.
Publicado: (2017)

Reproducibility of intracardiac and transpulmonary biomarkers in the evaluation of pulmonary hypertension
por: Monahan, Ken, et al.
Publicado: (2013)

Pharmacology and Rationale for Seralutinib in the Treatment of Pulmonary Arterial Hypertension
por: Pullamsetti, Soni Savai, et al.
Publicado: (2023)

Evidence of pulmonary arterial hypertension in two patients with common variable immunodeficiency
por: Huston, Jessica, et al.
Publicado: (2020)

Hemodynamic, Functional, and Clinical Responses to Pulmonary Artery Denervation in Patients With Pulmonary Arterial Hypertension of Different Causes: Phase II Results From the Pulmonary Artery Denervation-1 Study
por: Chen, Shao-Liang, et al.
Publicado: (2015)

CD44 and xCT: The Silver Bullet for Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension?
por: Agrawal, Vineet, et al.
Publicado: (2019)

Reduced free-living activity levels in pulmonary arterial hypertension patients
por: Halliday, Stephen J., et al.
Publicado: (2018)

Hemodynamic Improvement of Pulmonary Arterial Hypertension After Bariatric Surgery: Potential Role for Metabolic Regulation
por: Pugh, Meredith E., et al.
Publicado: (2013)

Phosphoproteomic analysis of lung tissue from patients with pulmonary arterial hypertension
por: Sitapara, Ravikumar, et al.
Publicado: (2021)

Approach to a patient with pulmonary hypertension
por: Inampudi, Chakradhari, et al.
Publicado: (2019)

An evidence-based knowledgebase of pulmonary arterial hypertension to identify genes and pathways relevant to pathogenesis
por: Zhao, Min, et al.
Publicado: (2014)

Clinical and genetic associations with prostacyclin response in pulmonary arterial hypertension
por: Halliday, Stephen J., et al.
Publicado: (2018)

Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Benza, Raymond L., et al.
Publicado: (2022)

Right ventricular remodelling in pulmonary arterial hypertension predicts treatment response
por: Goh, Ze Ming, et al.
Publicado: (2022)

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Biomarkers in pulmonary arterial hypertension
por: Minai, Omar A.
Publicado: (2014)

Authors’ reply: role of natriuretic peptide receptor C signalling in obesity-induced heart failure with preserved ejection fraction with pulmonary hypertension
por: Agrawal, Vineet, et al.
Publicado: (2020)

Identifying Patients with Pulmonary Arterial Hypertension Using Administrative Claims Algorithms
por: Mathai, Stephen C., et al.
Publicado: (2019)

Biomarkers in Pulmonary Arterial Hypertension
por: Hojda, Silvana Elena, et al.
Publicado: (2022)

Clinical features do not identify risk of progression from isolated postcapillary pulmonary hypertension to combined pre‐ and postcapillary pulmonary hypertension
por: Babu, Gautam, et al.
Publicado: (2023)

Pulmonary vascular effect of insulin in a rodent model of pulmonary arterial hypertension
por: Trammell, Aaron W., et al.
Publicado: (2017)

Mechanistic Phase II Clinical Trial of Metformin in Pulmonary Arterial Hypertension
por: Brittain, Evan L., et al.
Publicado: (2020)

Right Ventricular Adaptation Assessed Using Cardiac Magnetic Resonance Predicts Survival in Pulmonary Arterial Hypertension
por: Goh, Ze Ming, et al.
Publicado: (2021)

Peak steps: Capacity for activity improves after adding approved therapy in pulmonary arterial hypertension
por: Lachant, Daniel, et al.
Publicado: (2023)

An algorithm to identify cases of pulmonary arterial hypertension from the electronic medical record
por: Schuler, Kyle P., et al.
Publicado: (2022)

Anatomical characterization of pulmonary artery and implications to pulmonary artery pressure monitor implantation
por: Zafar, Hamza, et al.
Publicado: (2023)

Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association Registry
por: Chang, Kevin Y., et al.
Publicado: (2022)

Inspiratory flow patterns with dry powder inhalers of low and medium flow resistance in patients with pulmonary arterial hypertension
por: Faria-Urbina, Mariana, et al.
Publicado: (2021)

Arrhythmic Burden and Outcomes in Pulmonary Arterial Hypertension
por: Middleton, Jennifer T., et al.
Publicado: (2019)

Quantitative CT Evaluation of Small Pulmonary Vessels Has Functional and Prognostic Value in Pulmonary Hypertension
por: Shahin, Yousef, et al.
Publicado: (2022)

Predictors of Diastolic-To-Wedge Gradient in Patients Evaluated for Pulmonary Hypertension
por: Brittain, Evan L., et al.
Publicado: (2013)

Inhaled seralutinib exhibits potent efficacy in models of pulmonary arterial hypertension
por: Galkin, Anna, et al.
Publicado: (2022)

Novel biomarkers for pulmonary arterial hypertension
por: Anwar, Anjum, et al.
Publicado: (2016)

Diagnostic accuracy of CT pulmonary angiography in suspected pulmonary hypertension
por: Swift, Andrew J., et al.
Publicado: (2020)

SU5416 plus hypoxia but not selective VEGFR2 inhibition with cabozantinib plus hypoxia induces pulmonary hypertension in rats: potential role of BMPR2 signaling
por: Sitapara, Ravikumar, et al.
Publicado: (2021)

Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis
por: Rice, Lisa M., et al.
Publicado: (2018)

Machine learning cardiac-MRI features predict mortality in newly diagnosed pulmonary arterial hypertension
por: Alabed, Samer, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0mlacssg1mod8mh5b5r2fp6cn8